More about our sector?

this is your place

A story about adoption – Pharma 4.0 at the world’s largest insulin manufacturers


Pharma 4.0 is a popular topic in this years ISPE Annual Meeting event in Philly and currently of great interest in the industry as a whole. As with all new ideas and concepts, a certain level of misunderstanding and even skepticism exists. You may be wondering, what are the true benefits of all these technologies and how will they change my daily job? Pharma 4.0 is the ISPE’s attempt to adapt the promise of the digital transformation that is considered part of the 4th industrial revolution. It is a play on the term “Industry 4.0” that was born from a German government initiative – in other words, the 4th Industrial Revolution.

Revolution you ask, why is it a revolution? It promises a true paradigm shift in how we design and manufacture products and it promises an order of magnitude productivity increase. Equivalent to the move from horses to automobiles, from steam power to electricity, the introduction of the assembly line, and then the introduction of automation. Whether you are a skeptic or not, the facts are hard to dispute. I believe most manufacturing executives and our own pharmaceutical executives understand and therefore pushing the digital transformation – they do not want to miss the boat.

ISPE’s Pharma 4.0 working group is working hard to explain and define what the revolution means to us and how we can move our organizations into this brave new world. At Bigfinite, we consider ourselves to be enablers of Pharma 4.0. The Bigfinite platform was born from the new digital technologies with a unique focus on Life Sciences and specifically Pharma and Biotech manufacturing. Our customers are all embarking on their digital transformation journey and we are proud to tell their stories.

One of these companies is Novo Nordisk, who will be presenting with us at the ISPE Annual Meeting in Philadelphia. We will be sharing the story of Novo Nordisk’s adoption of the Bigfinite advanced analytics platform as part of their digital transformation. So please join us to hear about how Novo Nordisk started their journey with the Bigfinite platform. Also, we have been paired with Eli Lilly in this session, who will also share some of their stories on digital transformation and Pharma 4.0. So come and learn from the two largest insulin manufacturers in the world about how pharma can adopt digital technologies and Pharma 4.0!

Where: ISPE Annual Meeting Education Session: Next Generation Manufacturing Control at 11:00 – 12:30 on Monday Nov.5th

PS: you can also visit us at the exhibit hall booth #1040



Melissa Villalobos

Sales and Marketing Coordinator

Bigfinite Announces Additions to Executive Team

Bigfinite, Inc. (Bigfinite), the leading manufacturing data analytics platform company for regulated industries, today announced that Brian Sweeney, Lawrence Baisch and Glenn Griffin have been added to the leadership team.
Crystal Black VP of Marketing

AI Algorithm Qualification

Pharmaceuticals and Biotech companies have no doubt that Artificial Intelligence (AI) is here to stay. Nonetheless, the opportunities AI technology offers are developing at a slow pace in a rather conservative manufacturing industry, aimed at managing production risks under controls that are subject to strong regulations. Fear of change? Risk aversion? Likely not.
Jordi Guitart VP of Artificial Intelligence

Bigfinite Announces Senior Leadership Additions

Bigfinite, Inc. (Bigfinite), the leading manufacturing data analytics platform company for regulated industries, today announced that John Vitalie has been named Chief Executive Officer (CEO) and has been elected to the Board of Directors. David Merino has been named Chief Financial Officer (CFO) of Bigfinite.

Why Biotech and Pharma Need GxP for their Digital Transformation Projects Now

Technological Enhancements with Principal Component Analysis Combined with Artificial Intelligence

Bigfinite Closes Series B Financing with Atlantic Bridge and Honeywell Ventures to Drive Disruption in Manufacturing Analytics

2019 Xavier University AI Summit Reflections – Two Industries Ready for Change

Now that the dust has settled from the Xavier University AI Summit and our team is back to business, we’ve had time to process some of the highlights and key takeaways from the exciting event.  In the past few years, there has been a significant increase in the implementation of digital technologies into various industries that subsequently impacted the way we live, travel, and do business.  From driverless cars to 24/7 customer support chatbots, innovation and technology continue to spiral upward and as we’ve entered the 4th industrial revolution, and healthcare + biopharma should be no exception.  The Xavier University AI Summit is a great event that brings together a range of relevant stakeholders with common focus on artificial intelligence (AI).

Bigfinite and NNE Partnership

Bigfinite and NNE announced a strategic partner program agreement to collaborate around accelerating digital transformation within manufacturing operations at the world's leading pharmaceutical and biotech manufacturers. 

Where are Pharma Companies in the Age of Artificial Intelligence?

They say good things come to those who wait; we say good things come to those who wait but only the things left by the visionaries before them.  The pharmaceutical industry has long been known to lag in the adoption of new technology due to strong regulations. Even though regulators have recently begun to open up to several new ‘big data’ or pharma 4.0 technologies - the question remains, if pharma companies are doing the same?  In 2016, the European Pharmacopoeia 9.0 in Chapter 5.21 announced that neural networks (NN) and support vector machines (SVM) are valid chemometric techniques for processing analytical data sets. 

Data Scientist 4.0 – Bridging the World of Manufacturing and Data

Since the announcement of the 4th Industrial Revolution in 2011, multitudes of emerging technologies have transpired around “Industry 4.0”. Technologies such as digital twins, Industrial Internet of Things (IIoT), and cyber-physical systems have come into the scene as core elements, providing the necessary ingredients for a paradigm shift in manufacturing. Technologies around predictive analytics and artificial intelligence are pioneering new approaches with many use cases including predictive maintenance, autonomous process optimization, and pattern recognition - used to identify potential failures in real-time. Because of this, data science is becoming an invaluable discipline for our industry in order to transform information into knowledge.